SCHEMBL26961807

SCHEMBL26961807

CC(C)(C)OC(=O)N[C@H]1CS(=O)(=O)c2ccc(-c3nnc(C4(C#N)CCN(C(=O)OC(C)(C)C)CC4)o3)cc2N(Cc2ccc(Cl)cc2)C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ JAK2 O60674 1/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ TBK1 Q9UHD2 1/20 0.33
▸ PDK2 Q15119 2/20 0.32
▸ KDM1A O60341 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ GPR119 Q8TDV5 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ HTT P42858 1/20 0.32
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ NAMPT P43490 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ VEGFA P15692 1/20 0.31
▸ EGLN1 Q9GZT9 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ KMT2A Q03164 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26962120 0.87 JAK2 (0.34) SMN1; SMN2JAK2JAK1TBK1PDK2
SCHEMBL26961929 0.86 PDK2 (0.34) SMN1; SMN2PDK2THRBGPR119
SCHEMBL26962286 0.85 TRPC3 (0.36) SMN1; SMN2THRBGPR119CNR1CNR2
SCHEMBL26961932 0.84 NPY1R (0.32) PDK2CNR2LMNAUSP2HSD17B10
SCHEMBL26962142 0.84 HSD17B10 (0.33) PDK2THRBUSP2HSD17B10
SCHEMBL26962164 0.83 PDK2 (0.33) SMN1; SMN2PDK2LMNAUSP2HSD17B10
SCHEMBL26961749 0.81 AKT1 (0.33) THRBLMNAUSP2HSD17B10
SCHEMBL26961719 0.80 KDM4E (0.32) USP2HSD17B10
SCHEMBL26962012 0.80 PDK2 (0.30) PDK2
SCHEMBL26961699 0.79 RIPK1 (0.38) MEN1USP2KMT2AHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4291558-A1 BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER F. Hoffmann-La Roche AG (CH) 2023-12-20 — — EP disclosed
Send feedback